PortfoliosLab logo
GMED vs. SYK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GMED and SYK is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

GMED vs. SYK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globus Medical, Inc. (GMED) and Stryker Corporation (SYK). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GMED:

-0.30

SYK:

0.61

Sortino Ratio

GMED:

-0.10

SYK:

1.00

Omega Ratio

GMED:

0.98

SYK:

1.13

Calmar Ratio

GMED:

-0.24

SYK:

0.89

Martin Ratio

GMED:

-0.70

SYK:

2.72

Ulcer Index

GMED:

13.70%

SYK:

5.08%

Daily Std Dev

GMED:

36.91%

SYK:

22.09%

Max Drawdown

GMED:

-47.91%

SYK:

-58.63%

Current Drawdown

GMED:

-36.58%

SYK:

-4.10%

Fundamentals

Market Cap

GMED:

$8.02B

SYK:

$146.12B

EPS

GMED:

$1.33

SYK:

$7.46

PE Ratio

GMED:

44.28

SYK:

51.25

PEG Ratio

GMED:

1.70

SYK:

0.50

PS Ratio

GMED:

3.19

SYK:

6.29

PB Ratio

GMED:

1.95

SYK:

6.98

Total Revenue (TTM)

GMED:

$2.51B

SYK:

$23.22B

Gross Profit (TTM)

GMED:

$1.43B

SYK:

$14.76B

EBITDA (TTM)

GMED:

$486.48M

SYK:

$5.32B

Returns By Period

In the year-to-date period, GMED achieves a -28.45% return, which is significantly lower than SYK's 6.52% return. Over the past 10 years, GMED has underperformed SYK with an annualized return of 8.80%, while SYK has yielded a comparatively higher 16.16% annualized return.


GMED

YTD

-28.45%

1M

-17.54%

6M

-30.87%

1Y

-11.13%

3Y*

-3.86%

5Y*

1.61%

10Y*

8.80%

SYK

YTD

6.52%

1M

2.33%

6M

-1.97%

1Y

13.41%

3Y*

19.00%

5Y*

15.58%

10Y*

16.16%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Globus Medical, Inc.

Stryker Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GMED vs. SYK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMED
The Risk-Adjusted Performance Rank of GMED is 3333
Overall Rank
The Sharpe Ratio Rank of GMED is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of GMED is 3333
Sortino Ratio Rank
The Omega Ratio Rank of GMED is 3232
Omega Ratio Rank
The Calmar Ratio Rank of GMED is 3535
Calmar Ratio Rank
The Martin Ratio Rank of GMED is 3535
Martin Ratio Rank

SYK
The Risk-Adjusted Performance Rank of SYK is 7272
Overall Rank
The Sharpe Ratio Rank of SYK is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of SYK is 6565
Sortino Ratio Rank
The Omega Ratio Rank of SYK is 6464
Omega Ratio Rank
The Calmar Ratio Rank of SYK is 8181
Calmar Ratio Rank
The Martin Ratio Rank of SYK is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMED vs. SYK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current GMED Sharpe Ratio is -0.30, which is lower than the SYK Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of GMED and SYK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GMED vs. SYK - Dividend Comparison

GMED has not paid dividends to shareholders, while SYK's dividend yield for the trailing twelve months is around 0.86%.


TTM20242023202220212020201920182017201620152014
GMED
Globus Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SYK
Stryker Corporation
0.86%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%

Drawdowns

GMED vs. SYK - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum SYK drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for GMED and SYK.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GMED vs. SYK - Volatility Comparison

Globus Medical, Inc. (GMED) has a higher volatility of 28.22% compared to Stryker Corporation (SYK) at 5.15%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

GMED vs. SYK - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B20212022202320242025
598.12M
5.87B
(GMED) Total Revenue
(SYK) Total Revenue
Values in USD except per share items

GMED vs. SYK - Profitability Comparison

The chart below illustrates the profitability comparison between Globus Medical, Inc. and Stryker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20212022202320242025
67.3%
63.8%
(GMED) Gross Margin
(SYK) Gross Margin
GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a gross profit of 402.72M and revenue of 598.12M. Therefore, the gross margin over that period was 67.3%.

SYK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Stryker Corporation reported a gross profit of 3.74B and revenue of 5.87B. Therefore, the gross margin over that period was 63.8%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported an operating income of 97.00M and revenue of 598.12M, resulting in an operating margin of 16.2%.

SYK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Stryker Corporation reported an operating income of 837.00M and revenue of 5.87B, resulting in an operating margin of 14.3%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Globus Medical, Inc. reported a net income of 75.46M and revenue of 598.12M, resulting in a net margin of 12.6%.

SYK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Stryker Corporation reported a net income of 654.00M and revenue of 5.87B, resulting in a net margin of 11.2%.